Navigation Links
US Capital Global Advises on $2 Million Convertible Note Investment in Toolbox Genomics

US Capital Global is engaged as exclusive financial advisor on a $2 million convertible note investment in Toolbox Genomics, Inc., an emerging company in the genetic testing health field. Toolbox Genomics is dedicated to becoming the healthcare industry’s gold standard for turning individual DNA genetic testing results into scientifically-based, easy-to-understand, personalized lifestyle recommendations for actionable preventive care.

Headquartered in San Francisco, US Capital Global is a full-service private financial group with an established track record in investment banking and capital raise services. Its registered broker-dealer affiliate, US Capital Global Securities, LLC, is acting as the exclusive placement agent for this convertible note offering in Toolbox Genomics.

Didier Perez, CEO at Toolbox Genomics, said: “We are excited to be working with US Capital Global’s skilled advisory team as we move forward with our growth plans to bring to market actionable health recommendations based on a person’s individual DNA. With US Capital Global’s support and expertise, Toolbox Genomics is well-positioned to enhance its platform and pursue plans to go to market.”

“It is a pleasure serving Toolbox Genomics as its exclusive financial advisor,” said Charles Towle, Managing Partner at US Capital Global. “Our shared enthusiasm for Toolbox Genomics’ unique product was a key determinant in accepting this engagement. We believe the company is in a strong position to advance its strategic market expansion into the rapidly growing digital health sector. The opportunity to participate in Toolbox Genomics’ $2 million convertible note investment is now open to eligible investors.

About Toolbox Genomics
Toolbox Genomics develops personalized, DNA-based products that provide licensed healthcare practitioners, nutritionists, dietician, and wellness professionals with actionable, evidence-based Health Action Plans™ focused on nutrition, supplements, and exercise. Learn more at

About US Capital Global
Since 1998, the US Capital team has been committed to providing small and lower middle market businesses and investors with sophisticated debt, equity, and investment opportunities usually available only to larger middle market companies and institutional investors. The US Capital Global group manages direct investment funds and provides wealth management and capital raise services. Operating with its registered investment bank affiliate, US Capital Global Securities, LLC, the firm acts as a licensed placement agent for companies, funds, and projects, and collaborates closely with its peers in professional banking and investment advisory.

To learn more about US Capital Global Securities or this investment opportunity, email Charles Towle, CEO, at charles(at) or call +1 415-889-1010.

Read the full story at

Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved

Related medicine technology :

1. Health Velocity Capital Raises More Than $185 Million for Inaugural Fund
2. DabaDoc Raises Capital From Axa To Support Patients And Health Professionals
3. Carepoynt Closes $2MM Investment Round and Engages US Capital Global to Advise on Series A Venture Round
4. Human Microbiome Market to be Worth US$3.2 Billion by 2024: Rising Investments by Angel Investors and Venture Capital Firms to Drive Growth, Says TMR
5. Lilly Announces $850 Million Investment in U.S. Capital Projects in 2017
6. Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day
7. Medin Successfully Recapitalizes and Raises New Capital With Financial Partner
8. Atlantic Street Capital Portfolio Company Lombart Acquires INNOVA
9. ML Capital Group Acquires Stake in Colorado Highlife Tours Bolstering $1 Million 2017 Cannabis Tours Forecast
10. Noble Capital Markets Initiates Research Coverage on ESSA Pharma Inc. (EPIX)
11. Aralez to Present at the RBC Capital Markets Global Healthcare Conference
Post Your Comments:
(Date:7/13/2019)... Texas (PRWEB) , ... July 12, 2019 , ... ... million Americans’ ability to communicate and socialize with others. Given how widespread autism ... someone on the spectrum! While autism cannot be “cured,” there are treatment options ...
(Date:7/11/2019)... ... 11, 2019 , ... AngelEye Health, a leading provider of ... a clinical advisor. Jaylee will be focused on supporting hospital and health system ... a decade of progressive clinical experience, most recently serving as director of neonatal ...
(Date:7/11/2019)... ... July 11, 2019 , ... ... a strategic partnership with Palmer College of Chiropractic, the first and largest chiropractic ... has been specially selected to handle its billing and revenue cycle for the ...
Breaking Medicine Technology:
(Date:7/13/2019)... ... July 12, 2019 , ... ... been named a “Brand to Watch” by Brightfield Group, a leading cannabis research ... the top 10 of domestic CBD companies in two categories, Topicals and Skincare/Beauty. ...
(Date:7/13/2019)... (PRWEB) , ... July 12, 2019 , ... The American ... Report. This report is designed to help medical aesthetic and medical spa professionals understand ... from providers across the industry. , “It’s been two years since AmSpa released the ...
(Date:7/12/2019)... , ... July 12, 2019 , ... Rebecca Baxt, M.D., ... by NJ Top Docs for 2019. Located in Paramus, BAXT CosMedical is a renowned ... cosmetic and medical dermatological care for the past 45 years. , NJ Top Docs, ...
(Date:7/11/2019)... ... July 11, 2019 , ... The ... resources with a range of features to further advance their mission of delivering ... in manufacturing quality medicines for patients worldwide. The latest additions include a new ...
(Date:7/10/2019)... ... July 10, 2019 , ... Foggiare --the first and only U.S. ... effective beauty and wellness technology. Developed by Sauna Italia , an Italian manufacturer ... a proven success in over 180 locations in Europe and Asia. Slim-Up is scientifically ...
Breaking Medicine News(10 mins):